Alterity Therapeutics's market cap is currently $65.12M. The company's EPS TTM is $-0.000667285; its P/E ratio is -10.83; Alterity Therapeutics is scheduled to report earnings on February 28, 2025, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.